Skip to content

Short Intervention for Medication Overuse Headache (MOH) - Pilot

Pilot Study of Short Intervention for Medication Overuse Headache in General Practice

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01078012
Acronym
SIMOHpilot
Enrollment
5
Registered
2010-03-02
Start date
2010-03-31
Completion date
2011-06-30
Last updated
2015-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medication Overuse Headache

Brief summary

The purpose of the study is together with the BIMOH (NCT01314768) RCT study to evaluate whether training of GPs in the detection and treatment of medication overuse headache leads to improved care for these patients as compared to business as usual.

Detailed description

The present pilot study focuses on testing the logistics and the methodology of short intervention on a pilot group of GPs and their patients. Due to low recruitment and the pilot study focus on logistics and methodology, the study was changed to not include a control (business as usual) arm. The outcomes were evaluated as before - after data and qualitative comments on acceptability and utility of the method. Primary outcomes were changed to be the acceptability and utility (previously listed as secondary outcomes) while secondary outcomes were headache days and medication days (previously listed as primary).

Interventions

BEHAVIORALTrained counselling

Sponsors

Department of General Practice and Community Medicine, Oslo
CollaboratorUNKNOWN
Head and Neck Research Group, Lørenskog
CollaboratorUNKNOWN
University Hospital, Akershus
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed with medication overuse headache

Exclusion criteria

* Other complicating pain condition

Design outcomes

Primary

MeasureTime frame
Qualitative comments of participants on acceptability and utility2 months

Secondary

MeasureTime frame
Qualitative comments of participants on acceptability and utility.2 months
Number of medication days per month2 months

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026